An antisense strategy was chosen because a decrease in the
expression of the rCNGα gene (knock-down) can closely mimic a slow
retinal degeneration as observed in human RP disease, rather than a
complete loss of function (knock-out), which may cause a rapid
degeneration as seen in rhodopsin knockout.
24 Furthermore,
this approach allows the obtention of several lines of transgenic mice
expressing different levels of rCNGα RNA
(Figs. 5 6) . Such a
strategy requires the use of a very strong promoter, because a
sufficient amount of antisense RNA has to be expressed to inhibit the
synthesis of rCNGα protein (see
Fig. 2 ). The well-characterized
rhodopsin promoter would restrict transgene expression to rod
photoreceptors only.
28 Consequently, we used the CMV
promoter because its expression is not cell-specific (see
Fig. 4 ).
Thus, effects of the antisense construct can be studied in any cell
expressing the endogenous rCNGα gene. For example, expression of the
transgene was observed in the eye, brain, heart, and kidney
(Fig. 4) ,
where the endogenous rCNGα has been detected.
36 37 38 Despite the widespread distribution of the transgene, the mice do not
appear to suffer from any severe pathology, because they can live to be
more than 1 year of age with no obvious physiological defects. The
effects of the transgene in tissues other than the retina would be of
great interest in determining the role of the rod cGMP-gated channel in
other systems.